Remodeling of abdominal aortic aneurysm sac following endovascular aortic repair: association with clinical, surgical, and genetic factors

After successful endovascular aortic repair (EVAR), abdominal aortic aneurysms (AAA) sac will undergo negative remodeling (i.e., shrinkage) as a measure of successful exclusion. Determinants of shrinkage after EVAR are not fully known. In 84 post-EVAR patients, time course of AAA diameter after repair and occurrence of endoleaks (ELs) have been correlated with clinical history, medications, anthropometric data, vascular anatomy, and matrix metalloprotease (MMP) genetic variants (namely MMP-1 rs1799750, MMP-3 rs35068180, MMP-9 rs2234681, rs917576, rs917577, MMP-12 rs652438, and TIMP1 rs4898). During follow-up, 41 ELs were detected in 37 patients (44%, 10.4 events/100 pt./y), accounting for AAA dilation or reduced shrinkage ( P < .001). High-flow ELs (type 1 and/or 3) occurrence was associated with warfarin use, MMP9 rs17577 polymorphism, and unfavorable anatomy, while low-flow type 2 ELs occurred more often in TIMP1 rs4898 non-T carriers. In EL-free patients, AAA diameter decreased for the first three years, (-4,-3 and -2 mm/year respectively) and remained stable thereafter. Shrinkage between two measurements (n = 120) was associated with smaller AAA diameter at the baseline, peripheral ar-terial disease (PAD), patients' older age at intervention, and G -/G-genotype in MMP1 rs1799750 (binary logistic regression, P = .0 0 01). Aneurysmal sac shrinking occurs for few years after EVAR, only in patients without EL, and is re-lated to older age, PAD, smaller aneurysm size and putative lower MMP1 expression while EL occurrence prevents such a remodeling and is mainly related to local-acting factors like unfavorable anatomy, anti-coagulation, and MMP9 and TIMP1 genetic polymorphisms. (c) 2021 Elsevier Inc. All rights reserved.

Automated summary

This study indicates that the abdominal aortic aneurysm sac will undergo negative remodeling after EVAR, but the occurrence of endoleaks (ELs) can prevent this negative remodeling. High-flow ELs are associated with warfarin use, MMP9 rs17577 polymorphism, and unfavorable anatomy, while low-flow ELs occur more often in TIMP1 rs4898 non-T carriers.